| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16130065 |
| PharmacoGx | BRD-K16130065 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LDLRAD1 | CTRPv2 | pan-cancer | AAC | 0.38 | 3e-08 |
| mRNA | SFT2D2 | CTRPv2 | pan-cancer | AAC | 0.39 | 3e-08 |
| mRNA | SGSM1 | CTRPv2 | pan-cancer | AAC | 0.37 | 4e-08 |
| mRNA | GPR142 | CTRPv2 | pan-cancer | AAC | 0.37 | 4e-08 |
| mRNA | AZGP1 | CTRPv2 | pan-cancer | AAC | 0.39 | 5e-08 |
| mRNA | CHI3L1 | CTRPv2 | pan-cancer | AAC | 0.38 | 5e-08 |
| mRNA | AARD | CTRPv2 | pan-cancer | AAC | 0.38 | 6e-08 |
| mRNA | KLHL42 | CTRPv2 | pan-cancer | AAC | 0.37 | 7e-08 |
| mRNA | LAMC3 | CTRPv2 | pan-cancer | AAC | 0.38 | 7e-08 |
| mRNA | C19orf12 | CTRPv2 | pan-cancer | AAC | 0.38 | 8e-08 |
